HALOVSSBFM• 7 Days (Normalized)
HALO vs SBFM (Halozyme Therapeutics Inc. vs Sunshine Biopharma Inc.)
Showing Closing Date Range from Sep 30 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.72
-0.62%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
SBFM Performance $0.4
-48.53%
Sunshine Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+47.91 pts
HALO outperforming by 47.91 percentage points
HALOSBFM
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO SBFM
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | HALO Price | HALO Gain (%) | SBFM Price | SBFM Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $109.72 | -0.62% | $0.40 | -48.53% | +47.91% |
| Oct 05, 2026 | $108.31 | -1.89% | $0.42 | -45.65% | +43.76% |
| Oct 02, 2026 | $109.86 | -0.49% | $0.67 | -13.78% | +13.29% |
| Oct 01, 2026 | $106.94 | -3.13% | $- | - | |
| Sep 30, 2026 | $110.40 | +0.00% | $0.77 | +0.00% | +0.00% |